Your search returned 2 results.

Results
	1.	Lessons From Primary Cardiac Prevention Trials During Trastuzumab Therapy: End of One Size Fits All. MedStar authors: Barac, Ana PMID: 31171093 Year: 2019 Citation: Journal of the American College of Cardiology. 73(22):2869-2871, 2019 06 11. Institution: MedStar Heart & Vascular Institute Medline publication type: Editorial Form of publication: Journal Article All authors: Barac A, Blaes A, Lynce F DOI: https://dx.doi.org/10.1016/j.jacc.2019.04.006 Add to cart (remove)
	2.	Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. MedStar authors: Asch, Federico M Barac, Ana Cunningham, A Gallagher, Christopher Hofmeyer, Mark Srichai, M B Swain, Sandra M PMID: 30852761 Year: 2019 Citation: Breast Cancer Research & Treatment. 175(3):595-603, 2019 Jun. Institution: MedStar Health MedStar Health Research Institute MedStar Heart & Vascular Institute Washington Cancer Institute Department: Associate Dean for Research Development Medline publication type: Journal Article Form of publication: Journal Article All authors: Asch FM, Barac A, Cunningham A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Lynce F, Nunes R, Pohlmann PR, Shajahan-Haq A, Smith KL, Srichai MB, Swain SM, Tan MT, Timothee P, Warren R, Yu AF DOI: https://dx.doi.org/10.1007/s10549-019-05191-2 Add to cart (remove)

Refine your search